Jennifer Franke Selected Research

Jennifer Franke Research Topics

Disease

12	Heart Failure 01/2022 - 01/2011
6	Stroke (Strokes) 12/2020 - 04/2014
4	Myocardial Infarction 01/2021 - 04/2014
4	Atrial Fibrillation 01/2017 - 04/2014
4	Hypertension (High Blood Pressure) 08/2015 - 05/2012
3	Takotsubo Cardiomyopathy 05/2024 - 04/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 02/2012
2	Death (Near-Death Experience) 04/2016 - 03/2015
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2015 - 04/2014
2	Aortic Valve Stenosis (Aortic Stenosis) 04/2014 - 02/2013
2	Hemorrhage 04/2014 - 04/2014
2	Heart Diseases (Heart Disease) 03/2013 - 01/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Overweight 01/2020
1	Obesity 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Atrial Remodeling 01/2017
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 05/2016
1	Hemorrhagic Stroke 05/2016
1	Ischemic Stroke 05/2016
1	Thrombosis (Thrombus) 03/2016
1	Pain (Aches) 11/2015
1	Mental Disorders (Mental Disorder) 09/2015
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 08/2015
1	Atrial Heart Septal Defects (Atrial Septal Defect) 08/2015
1	Cardiomyopathies (Cardiomyopathy) 05/2015
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2015
1	Pathologic Constriction (Stenosis) 03/2015
1	ST Elevation Myocardial Infarction 04/2014
1	Embolic Stroke 04/2012
1	Fatigue 02/2012
1	Hypoxia (Hypoxemia) 02/2012
1	Dyspnea (Shortness of Breath) 02/2012
1	Systolic Heart Failure 12/2011
1	Hypotension (Low Blood Pressure) 01/2011
1	Myocarditis (Carditis) 01/2011

Drug/Important Bio-Agent (IBA)

4	Warfarin (Coumadin)FDA LinkGeneric 03/2016 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2014
2	TroponinIBA 01/2020 - 09/2015
2	Antihypertensive Agents (Antihypertensives)IBA 05/2016 - 02/2013
2	pro-brain natriuretic peptide (1-76)IBA 04/2015 - 12/2011
1	empagliflozinIBA 12/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	CreatinineIBA 01/2020
1	potassium channel protein TREK-1IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2016
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2016
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2016
1	Desmoplakins (Desmoplakin)IBA 05/2015
1	Myosins (Myosin)IBA 05/2015
1	Carrier Proteins (Binding Protein)IBA 05/2015
1	GadoliniumIBA 03/2015
1	MicroRNAs (MicroRNA)IBA 04/2014
1	ErbB-3 ReceptorIBA 03/2013
1	AntigensIBA 03/2013
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2013
1	Oxygen (Dioxygen)IBA 02/2012
1	IvabradineIBA 01/2011

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2009
5	Catheters 08/2015 - 05/2012
4	Denervation 08/2015 - 05/2012
3	Heart Transplantation (Grafting, Heart) 03/2015 - 01/2011
2	Percutaneous Coronary Intervention 01/2023 - 05/2016
2	Sympathectomy (Sympathectomies) 08/2015 - 02/2013
2	Contraindications 03/2015 - 04/2014
2	Transcatheter Aortic Valve Replacement 04/2014 - 02/2013
2	Drug Therapy (Chemotherapy) 01/2013 - 12/2011
1	Subacute Care 01/2023
1	Liver Transplantation 05/2016
1	Secondary Prevention 05/2016
1	Transplantation 04/2016
1	General Anesthesia 11/2015
1	Counterpulsation (External Counterpulsation) 01/2015
1	Stents 02/2013
1	Off-Label Use 01/2011
1	Heart-Assist Devices 01/2011